Cargando…

Noncommunicable diseases, access to essential medicines and universal health coverage

Universal Health Coverage is key to reach the overall health-related Sustainable Development Goal, and within this, access to safe, effective, quality, and affordable essential medicines is critical. Currently, medicines for noncommunicable diseases in many countries are not available when needed an...

Descripción completa

Detalles Bibliográficos
Autores principales: Beran, David, Pedersen, Hanne Bak, Robertson, Jane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781244/
https://www.ncbi.nlm.nih.gov/pubmed/31573421
http://dx.doi.org/10.1080/16549716.2019.1670014
_version_ 1783457322682548224
author Beran, David
Pedersen, Hanne Bak
Robertson, Jane
author_facet Beran, David
Pedersen, Hanne Bak
Robertson, Jane
author_sort Beran, David
collection PubMed
description Universal Health Coverage is key to reach the overall health-related Sustainable Development Goal, and within this, access to safe, effective, quality, and affordable essential medicines is critical. Currently, medicines for noncommunicable diseases in many countries are not available when needed and if they are present, are unaffordable. Countries face the challenges of rising prevalence of noncommunicable diseases due to increasing risk factors and ageing populations, along with under-diagnosis and under-treatment. Providing noncommunicable disease medicines is only one piece of a complex picture of providing care within Universal Health Coverage that requires strengthening health-care systems, as well as financial resources, priority setting, and monitoring and evaluation systems. Financing for Universal Health Coverage needs to enable adequate resources to be allocated for medicines with a focus on equity as well as priority setting for noncommunicable diseases medicines for reimbursement in benefits packages, efficient procurement and distribution of these medicines, supported by price regulation. These processes need to be evidence-based, transparent and grounded on national values and priorities. Monitoring and evaluation of availability and affordability are key components of sustainable reimbursement systems. With the current Universal Health Coverage agenda, the World Health Organization and countries can no longer ignore the issue of access to medicines for noncommunicable disease and need to develop the appropriate responses in order to guarantee equitable access.
format Online
Article
Text
id pubmed-6781244
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-67812442019-10-18 Noncommunicable diseases, access to essential medicines and universal health coverage Beran, David Pedersen, Hanne Bak Robertson, Jane Glob Health Action Current Debate Universal Health Coverage is key to reach the overall health-related Sustainable Development Goal, and within this, access to safe, effective, quality, and affordable essential medicines is critical. Currently, medicines for noncommunicable diseases in many countries are not available when needed and if they are present, are unaffordable. Countries face the challenges of rising prevalence of noncommunicable diseases due to increasing risk factors and ageing populations, along with under-diagnosis and under-treatment. Providing noncommunicable disease medicines is only one piece of a complex picture of providing care within Universal Health Coverage that requires strengthening health-care systems, as well as financial resources, priority setting, and monitoring and evaluation systems. Financing for Universal Health Coverage needs to enable adequate resources to be allocated for medicines with a focus on equity as well as priority setting for noncommunicable diseases medicines for reimbursement in benefits packages, efficient procurement and distribution of these medicines, supported by price regulation. These processes need to be evidence-based, transparent and grounded on national values and priorities. Monitoring and evaluation of availability and affordability are key components of sustainable reimbursement systems. With the current Universal Health Coverage agenda, the World Health Organization and countries can no longer ignore the issue of access to medicines for noncommunicable disease and need to develop the appropriate responses in order to guarantee equitable access. Taylor & Francis 2019-10-01 /pmc/articles/PMC6781244/ /pubmed/31573421 http://dx.doi.org/10.1080/16549716.2019.1670014 Text en © 2019 WHO. Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Current Debate
Beran, David
Pedersen, Hanne Bak
Robertson, Jane
Noncommunicable diseases, access to essential medicines and universal health coverage
title Noncommunicable diseases, access to essential medicines and universal health coverage
title_full Noncommunicable diseases, access to essential medicines and universal health coverage
title_fullStr Noncommunicable diseases, access to essential medicines and universal health coverage
title_full_unstemmed Noncommunicable diseases, access to essential medicines and universal health coverage
title_short Noncommunicable diseases, access to essential medicines and universal health coverage
title_sort noncommunicable diseases, access to essential medicines and universal health coverage
topic Current Debate
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781244/
https://www.ncbi.nlm.nih.gov/pubmed/31573421
http://dx.doi.org/10.1080/16549716.2019.1670014
work_keys_str_mv AT berandavid noncommunicablediseasesaccesstoessentialmedicinesanduniversalhealthcoverage
AT pedersenhannebak noncommunicablediseasesaccesstoessentialmedicinesanduniversalhealthcoverage
AT robertsonjane noncommunicablediseasesaccesstoessentialmedicinesanduniversalhealthcoverage